Literature DB >> 1744086

Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.

R S Kler1, S Jackson, K Bartlett, L A Bindoff, S Eaton, M Pourfarzam, F E Frerman, S I Goodman, N J Watmough, D M Turnbull.   

Abstract

We have used radio-high pressure liquid chromatography to study the acyl-CoA ester intermediates and the acylcarnitines formed during mitochondrial fatty acid oxidation. During oxidation of [U-14C]hexadecanoate by normal human fibroblast mitochondria, only the saturated acyl-CoA and acylcarnitine esters can be detected, supporting the concept that the acyl-CoA dehydrogenase step is rate-limiting in mitochondrial beta-oxidation. Incubations of fibroblast mitochondria from patients with defects of beta-oxidation show an entirely different profile of intermediates. Mitochondria from patients with defects in electron transfer flavoprotein and electron transfer flavoprotein:ubiquinone oxido-reductase are associated with slow flux through beta-oxidation and accumulation of long chain acyl-CoA and acylcarnitine esters. Increased amounts of saturated medium chain acyl-CoA and acylcarnitine esters are detected in the incubations of mitochondria with medium chain acyl-CoA dehydrogenase deficiency, whereas long chain 3-hydroxyacyl-CoA dehydrogenase deficiency is associated with accumulation of long chain 3-hydroxyacyl- and 2-enoyl-CoA and carnitine esters. These studies show that the control strength at the site of the defective enzyme has increased. Radio-high pressure liquid chromatography analysis of intermediates of mitochondrial fatty acid oxidation is an important new technique to study the control, organization and defects of the enzymes of beta-oxidation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  In situ assay of fatty acid β-oxidation by metabolite profiling following permeabilization of cell membranes.

Authors:  Regina Ensenauer; Ralph Fingerhut; Sonja C Schriever; Barbara Fink; Marc Becker; Nina C Sellerer; Philipp Pagel; Andreas Kirschner; Torsten Dame; Bernhard Olgemöller; Wulf Röschinger; Adelbert A Roscher
Journal:  J Lipid Res       Date:  2012-02-16       Impact factor: 5.922

2.  Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis.

Authors:  W Babidge; S Millard; W Roediger
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

3.  Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.

Authors:  J J Shen; D Matern; D S Millington; S Hillman; M D Feezor; M J Bennett; M Qumsiyeh; S G Kahler; Y T Chen; J L Van Hove
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

4.  Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.

Authors:  Edana Cassol; Vikas Misra; Susan Morgello; Gregory D Kirk; Shruti H Mehta; Dana Gabuzda
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

Review 5.  Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

Authors:  R J Wanders; P Vreken; M E den Boer; F A Wijburg; A H van Gennip; L IJlst
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

6.  In Vitro Monitoring of the Mitochondrial Beta-Oxidation Flux of Palmitic Acid and Investigation of Its Pharmacological Alteration by Therapeutics.

Authors:  Renata Murgasova; Ester Tor Carreras; Julien Bourgailh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

7.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

8.  Analysis of organic acids after incubation with (16-2H3)palmitic acid in fibroblasts from patients with mitochondrial beta-oxidation defects.

Authors:  J H Osorio; M Lluch; A Ribes
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  Combined enzyme defect of mitochondrial fatty acid oxidation.

Authors:  S Jackson; R S Kler; K Bartlett; H Briggs; L A Bindoff; M Pourfarzam; D Gardner-Medwin; D M Turnbull
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Lipid metabolism in rats is modified by nitric oxide availability through a Ca++-dependent mechanism.

Authors:  Carlos A Marra; Julio Nella; Damián Manti; María J T de Alaniz
Journal:  Lipids       Date:  2007-01-19       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.